Claims
- 1. A method of inhibiting vasoconstriction, said method comprising administering to a mammal in need thereof a composition comprising nitrosylhemoglobin for a time and under conditions to inhibit vasoconstriction.
RELATED APPLICATIONS
This application is a continuation of PCT/US98/02383 filed on Feb. 5, 1998, which is a continuation-in-part of U.S. application Ser. No. 08/874,992 filed on Jun. 12, 1997, which is a continuation-in-part of U.S. application Ser. No. 08/796,164 filed on Feb. 6, 1997, which is a continuation-in-part of PCT/US96/14659 filed on Sep. 13, 1996, which is a continuation of U.S. application Ser. No. 08/667,003 filed on Jun. 20, 1996, now U.S. Pat. No. 6,197,745 which is a continuation-in-part of U.S. application Ser. No. 08/616,371 filed on Mar. 15, 1996, which claims the benefit of U.S. Provisional Application No. 60/003,801 filed on Sep. 15, 1995. The teachings of all of the above applications are each incorporated herein by reference in their entirety.
GOVERNMENT SUPPORT
This invention was made with government support under Grant Nos. HL52529 and HR59130 awarded by the National Institutes of Health. The government has certain rights in the invention.
US Referenced Citations (31)
Foreign Referenced Citations (14)
Number |
Date |
Country |
WO 9309806 |
May 1993 |
WO |
WO 9321525 |
Oct 1993 |
WO |
WO 9422306 |
Oct 1994 |
WO |
WO 9422482 |
Oct 1994 |
WO |
WO 9422499 |
Oct 1994 |
WO |
WO 9505397 |
Feb 1995 |
WO |
WO 9507691 |
Mar 1995 |
WO |
WO 9603139 |
Feb 1996 |
WO |
WO 9615797 |
May 1996 |
WO |
WO 9616645 |
Jun 1996 |
WO |
WO 9617604 |
Jun 1996 |
WO |
WO 9630006 |
Oct 1996 |
WO |
WO 9718000 |
May 1997 |
WO |
WO 9737644 |
Oct 1997 |
WO |
Non-Patent Literature Citations (3)
Entry |
Jia, L., et al., “S-Nitrosohaemoglobin: A Dynamic Activity of Blood Involved in Vascular Control,” Nature, 380:221-226 (1996). |
Ignarro, L.J., et al., “Mechanism of Vascular Smooth Muscle Relaxation by Organic Nitrates, Nitrites, Nitroprusside and Nitric Oxide: Evidence for the Involvement of S-Nitrosothiols as Active Intermediates,” The Journal of Pharmacology and Experimental Therapeutics, 218(3):739-749 (1981). |
Khartitonov, V.G., et al., “Interactions of Nitric Oxide with Heme Proteins Using UV-VIS Spectroscopy,” Methods in Nitric Oxide Research, pp. 39-45, Edited by Martin Feelisch and Jonathan S. Stamler, John Wiley & Sons Ltd. (1996). |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/003801 |
Sep 1995 |
US |
Continuations (2)
|
Number |
Date |
Country |
Parent |
PCT/US98/02383 |
Feb 1998 |
US |
Child |
09/369966 |
|
US |
Parent |
08/667003 |
Jun 1996 |
US |
Child |
PCT/US96/14659 |
|
US |
Continuation in Parts (4)
|
Number |
Date |
Country |
Parent |
08/874992 |
Jun 1997 |
US |
Child |
PCT/US98/02383 |
|
US |
Parent |
08/796164 |
Feb 1997 |
US |
Child |
08/874992 |
|
US |
Parent |
PCT/US96/14659 |
Sep 1996 |
US |
Child |
08/796164 |
|
US |
Parent |
08/616371 |
Mar 1996 |
US |
Child |
08/667003 |
|
US |